D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 21,507 477 World Ranking 13451 National Ranking 7092

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Internal medicine, Multiple myeloma, Surgery, Transplantation and Gastroenterology are his primary areas of study. His research investigates the connection between Internal medicine and topics such as Oncology that intersect with issues in Newly diagnosed. His Multiple myeloma study deals with the bigger picture of Immunology.

Many of his research projects under Surgery are closely connected to In patient with In patient, tying the diverse disciplines of science together. His Hematopoietic stem cell transplantation study, which is part of a larger body of work in Transplantation, is frequently linked to Plerixafor, bridging the gap between disciplines. His study explores the link between Lenalidomide and topics such as Bortezomib that cross with problems in Regimen.

His most cited work include:

  • Improved survival in multiple myeloma and the impact of novel therapies (1718 citations)
  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients (768 citations)
  • Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma (570 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Multiple myeloma, Surgery, Oncology and Gastroenterology. His Internal medicine and Lenalidomide, Transplantation, Amyloidosis, Autologous stem-cell transplantation and AL amyloidosis investigations all form part of his Internal medicine research activities. His Amyloidosis research integrates issues from Immunoglobulin light chain, Hematologic Response, Chemotherapy and Immunoglobulin Light-chain Amyloidosis.

Francis K. Buadi works mostly in the field of Multiple myeloma, limiting it down to topics relating to Dexamethasone and, in certain cases, Cyclophosphamide. His work on Progression-free survival as part of general Oncology research is often related to In patient, thus linking different fields of science. His research integrates issues of Survival rate, Bone marrow and Very Good Partial Response in his study of Gastroenterology.

He most often published in these fields:

  • Internal medicine (70.31%)
  • Multiple myeloma (55.81%)
  • Surgery (30.23%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (70.31%)
  • Multiple myeloma (55.81%)
  • Oncology (27.22%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Internal medicine, Multiple myeloma, Oncology, Amyloidosis and AL amyloidosis. Internal medicine connects with themes related to Gastroenterology in his study. His research in Multiple myeloma intersects with topics in Retrospective cohort study, Newly diagnosed, Bone marrow and Hematopoietic stem cell transplantation.

His Oncology research focuses on Lenalidomide and how it connects with Bortezomib. Francis K. Buadi has researched Amyloidosis in several fields, including Immunoglobulin light chain, Hematologic Response, Stage and Very Good Partial Response. His AL amyloidosis study incorporates themes from Cancer research, Chromosomal translocation, Urology, Venetoclax and Proteinuria.

Between 2018 and 2021, his most popular works were:

  • Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial (84 citations)
  • Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma. (52 citations)
  • Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis (46 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Francis K. Buadi mainly focuses on Internal medicine, Multiple myeloma, AL amyloidosis, Gastroenterology and Oncology. His multidisciplinary approach integrates Internal medicine and In patient in his work. His Multiple myeloma research is multidisciplinary, incorporating elements of Anemia, Retrospective cohort study, Stem cell, Monoclonal protein and Transplantation.

His AL amyloidosis study integrates concerns from other disciplines, such as Interquartile range, Urology, Minimal residual disease, Kidney and Amyloidosis. The study incorporates disciplines such as Odds ratio, Renal function, Multivariate analysis, Confidence interval and Bone marrow in addition to Gastroenterology. In his research on the topic of Oncology, Standard of care is strongly related with Lenalidomide.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Improved survival in multiple myeloma and the impact of novel therapies

Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy.
Blood (2008)

2418 Citations

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz.
Leukemia (2014)

1058 Citations

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Philippe Moreau;Tamás Masszi;Norbert Grzasko;Nizar J Bahlis.
The New England Journal of Medicine (2016)

844 Citations

A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

David S. Siegel;Thomas Martin;Michael Wang;Ravi Vij.
Blood (2012)

716 Citations

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

Shaji Kumar;Angela Dispenzieri;Martha Q. Lacy;Suzanne R. Hayman.
Journal of Clinical Oncology (2012)

690 Citations

Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

Shaji K. Kumar;Joseph R. Mikhael;Francis K. Buadi;David Dingli.
Mayo Clinic Proceedings (2009)

491 Citations

Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma

Martha Q. Lacy;Suzanne R. Hayman;Morie A. Gertz;Angela Dispenzieri.
Journal of Clinical Oncology (2009)

386 Citations

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.

S Kumar;A Dispenzieri;M Q Lacy;S R Hayman.
Leukemia (2007)

363 Citations

Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component

John A. Lust;Martha Q. Lacy;Steven R. Zeldenrust;Angela Dispenzieri.
Mayo Clinic proceedings (2009)

301 Citations

Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy

Stephen J. Russell;Mark J. Federspiel;Kah Whye Peng;Caili Tong.
Mayo Clinic Proceedings (2014)

298 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Francis K. Buadi

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 217

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 185

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 178

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 170

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 158

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 151

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 131

Sagar Lonial

Sagar Lonial

Emory University

Publications: 128

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 123

Pieter Sonneveld

Pieter Sonneveld

Erasmus University Rotterdam

Publications: 119

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 118

Evangelos Terpos

Evangelos Terpos

National and Kapodistrian University of Athens

Publications: 113

Giampaolo Merlini

Giampaolo Merlini

University of Pavia

Publications: 110

Michele Cavo

Michele Cavo

University of Bologna

Publications: 103

Maria-Victoria Mateos

Maria-Victoria Mateos

University of Salamanca

Publications: 102

Hartmut Goldschmidt

Hartmut Goldschmidt

University Hospital Heidelberg

Publications: 97

Trending Scientists

Rudolf Kruse

Rudolf Kruse

Otto-von-Guericke University Magdeburg

Kaiqi Huang

Kaiqi Huang

Chinese Academy of Sciences

Jianguo Sun

Jianguo Sun

University of Missouri

Foster Provost

Foster Provost

New York University

Michael Schlechtweg

Michael Schlechtweg

Fraunhofer Society

Alan J. Guwy

Alan J. Guwy

UNSW Sydney

Roland Bodmeier

Roland Bodmeier

Freie Universität Berlin

Fabio Ragaini

Fabio Ragaini

University of Milan

Jacob L. Jones

Jacob L. Jones

North Carolina State University

Ge Sun

Ge Sun

Research Triangle Park Foundation

Drewe Ferguson

Drewe Ferguson

Commonwealth Scientific and Industrial Research Organisation

Samuel L. Jaccard

Samuel L. Jaccard

University of Bern

K. R. Chan

K. R. Chan

Ames Research Center

Shirley Reynolds

Shirley Reynolds

University of Reading

Phyllis C. Zee

Phyllis C. Zee

Northwestern University

Khurram Nasir

Khurram Nasir

Houston Methodist

Something went wrong. Please try again later.